PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
03-Feb-2020 Trefoil Therapeutics Selects AGC Biologics as Lead Manufacturer of TTHX1114 for Treatment of Corneal Diseases AGC Biologics
03-Feb-2020 China Jo-Jo Drugstores Steps in to Help Combat the 2019 Novel Coronavirus China Jo-Jo Drugstores, Inc.
03-Feb-2020 FDA and FTC Announce New Efforts to Further Deter Anti-Competitive Business Practices, Support Competitive Market for Biological Products to Help Americans U.S. Food and Drug Administration
03-Feb-2020 Inceptua appoints new Head of Asia-Pacific, Clinical Trial Services Inceptua
03-Feb-2020 Applied Photophysics board appoints Tim Flanagan as CEO Applied Photophysics
03-Feb-2020 CO.DON AG: CO.DON AG launches new website CO.DON AG
03-Feb-2020 RauCon Pharma Partnering Conferences Limit Attendance For More Value B3C newswire
03-Feb-2020 MOLOGEN AG: Opening of insolvency proceedings MOLOGEN AG
03-Feb-2020 Biofrontera AG: European Medicines Agency recommends indication expansion of Ameluz(R) for treatment of actinic keratoses on the extremities and trunk/neck Biofrontera AG
03-Feb-2020 Hypha Discovery and Cypex announce a partnership to expand client access to drug metabolites Sciad Communications Ltd
03-Feb-2020 RHÖN-KLINIKUM AG to Make Active Use in 2020 of Opportunities When Healthcare Market is Shaken Up RHÖN-KLINIKUM AG
03-Feb-2020 Hypha Discovery and Cypex announce a partnership to expand client access to drug metabolites Sciad Newswire
31-Jan-2020 Vanda Pharmaceuticals Comments on Court Ruling Vanda Pharmaceuticals Inc.
31-Jan-2020 Biofrontera AG: Biofrontera AG
31-Jan-2020 CHMP issues positive opinions for both bempedoic acid and the bempedoic acid / ezetimibe fixed dose combination tablet as treatments for primary hypercholesterolaemia or mixed dyslipidaemia Daiichi Sankyo Europe
31-Jan-2020 Allergan to Report Fourth Quarter and Full Year 2019 Financial Results Allergan plc
31-Jan-2020 AbbVie Receives Positive CHMP Opinion for MAVIRET® (glecaprevir/pibrentasvir) to Shorten Treatment Duration to Eight Weeks in Genotype 3, Treatment-Naïve Patients with Chronic Hepatitis C and Compensated Cirrhosis AbbVie
31-Jan-2020 AbbVie Receives Positive CHMP Opinion for VENCLYXTO® as a Chemotherapy-Free Combination Regimen for Patients with Previously Untreated Chronic Lymphocytic Leukemia AbbVie
31-Jan-2020 Clinerion and Datametrix partner to deliver Real World Evidence (RWE) insights from Real World Data (RWD) from Clinerion’s global hospital network. Clinerion Ltd
31-Jan-2020 4SC - Resminostat and RESMAIN Study Update 4SC AG